皮下脂肪组织的多巴胺D2受体在糖尿病前期和T2D中增加
Milica Vranic1, Fozia Ahmed1, Robin Kristófi1
1Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
Endocrine
|September 26, 2023
概括
多巴胺受体D2 (DRD2) 蛋白在2型糖尿病 (T2D) 患者的脂肪组织中升高,这表明它在代谢调节中的作用. 多巴胺激动剂可以通过抑制脂解来改善脂代谢.
科学领域:
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
- 分子生物学分子生物学
背景情况:
- 多巴胺信号传递在中枢神经系统中至关重要,但它在人类脂肪组织中的作用不太清楚.
- 肥胖和2型糖尿病 (T2D) 是复杂的代谢障碍,与改变的信号通路有关.
研究的目的:
- 研究人类脂肪组织中的多巴胺信号传递,特别是多巴胺受体D1 (DRD1) 和D2 (DRD2).
- 评估DRD1和DRD2表达和肥胖和T2D中的代谢参数之间的关系.
- 确定多巴胺及其受体激动剂对脂肪组织代谢的直接影响.
主要方法:
- 在瘦身,肥胖和T2D患者的皮下脂肪组织中检查DRD1和DRD2的mRNA和蛋白质表达.
- 与肥胖,胰岛素抵抗和高血糖症的临床标志物相关的受体表达.
- 在多巴胺或受体特异性激动剂刺激后,评估脂肪细胞中的葡萄糖吸收和脂解.
主要成果:
- 在非糖尿病患者中,DRD1和DRD2基因表达与胰岛素耐药性和肥胖性标志物相关.
- 患有禁食葡萄糖和T2D受试者的DRD2蛋白水平较高,与高血糖相关.
- 多巴胺受体激动剂抑制了脂肪细胞中的脂解,但没有影响葡萄糖吸收.
结论:
- 脂肪组织中的DRD2蛋白表达在高血糖和T2D中被上调.
- 在T2D病原体中DRD2的确切作用需要进一步研究.
- 多巴胺激动剂可能通过调节脂解来影响脂质代谢,这可能解释了与布罗莫克里普丁等药物观察到的治疗益处.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
01:36Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
01:22Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
01:20Pathophysiology of Diabetes
971
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
971
01:24Obesity
523
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
523
01:24Glucagon-like Receptor Agonists
348
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
348